An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

This bill amends Pennsylvania's drug laws to create a formal process for adding new opioid overdose reversal medications to state standing orders. It requires the Department of Health to review new drugs, accept public comments, and publish decisions within specific timeframes before updating the list of approved medications. The legislation also allows interested parties to petition for the reconsideration of previously rejected drugs if new information becomes available. By establishing these clear steps, the bill aims to streamline how emergency overdose treatments are authorized and made available for use.